THE OFF-LABEL USE OF ATYPICAL ANTIPSYCHOTICS AND ITS IMPACT ON ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD)
Atypical antipsychotics (AAPs) (also known as second-generation antipsychotics) are the US Food and Drug Administration (FDA) approved medications for schizophrenia, bipolar I disorder, depression and autism. Compared to the typical antipsychotics, AAPs were marketed as reducing adverse side effects...
| Main Author: | |
|---|---|
| Format: | Others |
| Published: |
UKnowledge
2014
|
| Subjects: | |
| Online Access: | http://uknowledge.uky.edu/pharmacy_etds/33 http://uknowledge.uky.edu/cgi/viewcontent.cgi?article=1035&context=pharmacy_etds |